134 related articles for article (PubMed ID: 38105913)
1. Effect of Repeated Intravitreal Injections in Glaucoma Spectrum Diseases [Response to Letter].
Vilares-Morgado R; Ferreira AM; Rocha-Sousa A; Carneiro Â; Barbosa-Breda J
Clin Ophthalmol; 2023; 17():3799-3800. PubMed ID: 38105913
[No Abstract] [Full Text] [Related]
2. Effect of Repeated Intravitreal Injections in Glaucoma Spectrum Diseases [Letter].
Budu ; Esa T; Idrus HH
Clin Ophthalmol; 2023; 17():3703-3704. PubMed ID: 38073673
[No Abstract] [Full Text] [Related]
3. Intraocular pressure changes related to intravitreal injections of ranibizumab: analysis of pseudophakia and glaucoma subgroup.
Demirel S; Yanik O; Batioglu F; Ozmert E
Int Ophthalmol; 2015 Aug; 35(4):541-7. PubMed ID: 25079762
[TBL] [Abstract][Full Text] [Related]
4. Effect of Repeated Intravitreal Injections in Glaucoma Spectrum Diseases.
Vilares-Morgado R; Correia V; Ferreira AM; Alves F; Melo AB; Estrela-Silva S; Araújo J; Tavares-Ferreira J; Silva M; Rocha-Sousa A; Carneiro A; Barbosa-Breda J
Clin Ophthalmol; 2023; 17():3613-3627. PubMed ID: 38026596
[TBL] [Abstract][Full Text] [Related]
5. Sustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agents.
Good TJ; Kimura AE; Mandava N; Kahook MY
Br J Ophthalmol; 2011 Aug; 95(8):1111-4. PubMed ID: 20702430
[TBL] [Abstract][Full Text] [Related]
6. The effects of intravitreal injections on intraocular pressure and retinal nerve fiber layer: a systematic review and meta-analysis.
de Vries VA; Bassil FL; Ramdas WD
Sci Rep; 2020 Aug; 10(1):13248. PubMed ID: 32764619
[TBL] [Abstract][Full Text] [Related]
7. Rates of RNFL Thinning in Patients with Suspected or Confirmed Glaucoma Receiving Unilateral Intravitreal Injections for Exudative AMD.
Swaminathan SS; Kunkler AL; Quan AV; Medert CM; Vanner EA; Feuer W; Chang TC
Am J Ophthalmol; 2021 Jun; 226():206-216. PubMed ID: 33359714
[TBL] [Abstract][Full Text] [Related]
8. Rate of intraoperative complications during cataract surgery following intravitreal injections.
Hahn P; Jiramongkolchai K; Stinnett S; Daluvoy M; Kim T
Eye (Lond); 2016 Aug; 30(8):1101-9. PubMed ID: 27229705
[TBL] [Abstract][Full Text] [Related]
9. The link between intravitreal antivascular endothelial growth factor injections and glaucoma.
SooHoo JR; Seibold LK; Kahook MY
Curr Opin Ophthalmol; 2014 Mar; 25(2):127-33. PubMed ID: 24406814
[TBL] [Abstract][Full Text] [Related]
10. Effects of Intravitreal Anti-VEGF Therapy on Glaucoma-like Progression in Susceptible Eyes.
Du J; Patrie JT; Prum BE; Netland PA; Shildkrot YE
J Glaucoma; 2019 Dec; 28(12):1035-1040. PubMed ID: 31633617
[TBL] [Abstract][Full Text] [Related]
11. "Glaucomatous fields" after monthly intravitreal injections: Normal tension glaucoma or a mimicker?
Shah SM; Khanna CL; Yamanuha J; Bakri SJ
Am J Ophthalmol Case Rep; 2020 Dec; 20():100904. PubMed ID: 32964169
[TBL] [Abstract][Full Text] [Related]
12. The Effect of Anti-Vascular Endothelial Growth Factor Agents on Intraocular Pressure and Glaucoma: A Report by the American Academy of Ophthalmology.
Hoguet A; Chen PP; Junk AK; Mruthyunjaya P; Nouri-Mahdavi K; Radhakrishnan S; Takusagawa HL; Chen TC
Ophthalmology; 2019 Apr; 126(4):611-622. PubMed ID: 30472176
[TBL] [Abstract][Full Text] [Related]
13. Risk, Prevalence, and Progression of Glaucoma in Eyes With Age-Related Macular Degeneration Treated With Intravitreal Anti-Vascular Endothelial Growth Factor Injections.
Shah SM; Boopathiraj N; Starr MR; Dalvin LA; AbouChehade J; Damento G; Garcia MD; Hodge DO; Bakri SJ; Sit AJ; Iezzi R
Am J Ophthalmol; 2022 Nov; 243():98-108. PubMed ID: 35932820
[TBL] [Abstract][Full Text] [Related]
14. Short-term intraocular pressure trends following intravitreal ranibizumab injections for neovascular age-related macular degeneration-the role of oral acetazolamide in protecting glaucoma patients.
Murray CD; Wood D; Allgar V; Walters G; Gale RP
Eye (Lond); 2014 Oct; 28(10):1218-22. PubMed ID: 25081290
[TBL] [Abstract][Full Text] [Related]
15. [Late and sustained intraocular pressure elevation related to intravitreal anti-VEGF injections: Cases requiring filtering surgery (French translation of the article)].
Leleu I; Penaud B; Blumen-Ohana E; Rodallec T; Adam R; Laplace O; Akesbi J; Nordmann JP
J Fr Ophtalmol; 2018 Nov; 41(9):789-801. PubMed ID: 30348599
[TBL] [Abstract][Full Text] [Related]
16. Effects of Postoperative Intravitreal Injections on Outcomes of Traditional Glaucoma Surgery in Patients with Preoperative Intravitreal Injections.
Chang EK; Gupta S; Hall N; Neeson CE; Chang TC; Solá-Del Valle DA
Ophthalmol Glaucoma; 2022; 5(2):219-228. PubMed ID: 34500121
[TBL] [Abstract][Full Text] [Related]
17. [Age-related macular degeneration and glaucoma: intraocular pressure monitoring after intravitreal injections].
Avetisov SE; Erichev VP; Budzinskaia MV; Karpilova MA; Gurova IV; Shchegoleva IV; Chikun EA
Vestn Oftalmol; 2012; 128(6):3-5. PubMed ID: 23367753
[TBL] [Abstract][Full Text] [Related]
18. Effect of diode laser trans-scleral cyclophotocoagulation in the management of glaucoma after intravitreal silicone oil injection for complicated retinal detachments.
Han SK; Park KH; Kim DM; Chang BL
Br J Ophthalmol; 1999 Jun; 83(6):713-7. PubMed ID: 10340982
[TBL] [Abstract][Full Text] [Related]
19. The acute and chronic effects of intravitreal anti-vascular endothelial growth factor injections on intraocular pressure: A review.
Bracha P; Moore NA; Ciulla TA; WuDunn D; Cantor LB
Surv Ophthalmol; 2018; 63(3):281-295. PubMed ID: 28882597
[TBL] [Abstract][Full Text] [Related]
20. Repeated intravitreal anti-vascular endothelial growth factor injections can induce iatrogenic ocular hypertension, especially in patients with open-angle glaucoma.
Agard E; Elchehab H; Ract-Madoux G; Russo A; Lagenaite C; Dot C
Can J Ophthalmol; 2015 Apr; 50(2):127-31. PubMed ID: 25863852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
